Sapience Therapeutics Inc
Harrison, United States
Jim Rotolo is the VP of Translational Pharmacology and Head of Research at Sapience Therapeutics, where he is leading the Company's discovery and pre-clinical development efforts. Dr. Rotolo holds a B.S. in Chemistry from Emory University, an M.S. in Pharmacology and Toxicology from Long Island University, and a Ph.D. in Pharmacology and Immunology from the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan-Kettering Cancer Center. His work has resulted in over 20 publications and multiple patents/patent applications.